Progress in treatment of hypersplenism in patients with post-hepatitis cirrhosis
10.3969/j.issn.1001-5256.2015.11.042
- VernacularTitle:肝硬化患者脾功能亢进治疗研究进展
- Author:
Yan LIANG
1
;
Wenjing YI
;
Zhansheng JIA
Author Information
1. The Center of Infectious Disease Diagnosis and Treatment of PLA, Tangdu Hospital, Forth Military Medical University, Xi′an 710038, China
- Publication Type:Research Article
- Keywords:
liver cirrhosis;
hypersplenism;
review
- From:
Journal of Clinical Hepatology
2015;31(11):1924-1927
- CountryChina
- Language:Chinese
-
Abstract:
Hypersplenism is a common complication of post-hepatitis cirrhosis, and may not need to be treated. The treatment of hypersplenism is not considered if it is not proven clinically beneficial to patients. However, there are still some patients with hypersplenism who should be treated for some reasons. This article reviews the latest progress in the therapies for hypersplenism, including splenectomy, splenic artery embolization, splenic radiofrequency ablation, liver transplantation, medication, and transjugular intrahepatic portosystemic shunt. It is demonstrated that all the above treatments have advantages and disadvantages. Minimally invasive methods, through currently preferred for hypersplenism, have not yet been clinically applied for a long period, and remain to be technically improved and supported by relevant evidence for standardization.
